Cyclica is the partner of choice for data-driven drug discovery. We advance molecules that embrace the complexity of the disease.
Our computational approach to polypharmacology is unique in the industry. We use a proteome-wide lens to evaluate multiple novel and rare on and off-target interactions simultaneously.
We’re also the only company of our kind that integrates science to advance molecules downstream. A structure-based view keeps our work accountable to biology, chemistry, physics, and genomics.
To learn more about Cyclica and how we partner, please visit www.cyclicarx.com
Our computational approach to polypharmacology is unique in the industry. We use a proteome-wide lens to evaluate multiple novel and rare on and off-target interactions simultaneously.
We’re also the only company of our kind that integrates science to advance molecules downstream. A structure-based view keeps our work accountable to biology, chemistry, physics, and genomics.
To learn more about Cyclica and how we partner, please visit www.cyclicarx.com
Location: Canada, Ontario, Toronto
Phone: +1 416-304-9201
Total raised: $27.8M
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 18.11.2022 | Grant | $2.4M | - |
| 23.06.2020 | Series B | $23M | - |
| 23.09.2016 | - | $2.4M | - |
Mentions in press and media 23
| Date | Title | Description |
| 17.08.2023 | 10 Greek M&A Deals in 2023 You Should Know About | Greece ~ Company: As we delve deeper into 2023, the Greek M&As 2023 landscape has been marked by a series of significant business consolidations. Spanning diverse sectors from cybersecurity to biotechnology, these M&As offer a compr... |
| 31.07.2023 | 4 Ways Biopharma Is Applying AI/ML to Improve Drug Development Outcomes | Healthcare innovation in drug development intersects with a few critical trends: the rise of artificial intelligence (AI) applications in healthcare—particularly machine learning (ML) and predictive analytics; the need to reduce the costs a... |
| 15.11.2022 | HLTH22: Cyclica Awarded $1.8M Grant from Bill & Melinda Gates Foundation to Discover Non-Hormonal Contraceptive | What You Should Know: As a neo-biotech, Cyclica is efficiently advancing an industry-leading, robust and sustainable drug discovery portfolio focused on CNS, oncology, and auto-immune diseases. Cyclica has built the only generalizable platf... |
| 15.11.2022 | HLTH22 Day 2 News Summary: Amazon Clinic Launch, General Catalyst, Verizon, Higi | Amazon Launches Amazon Clinic Across 32 States Amazon Web Services (AWS) launches two new capabilities in HealthLake that deliver innovations for medical imaging and analytics: – Amazon HealthLake Imaging is a new HIPAA-eligible capability ... |
| 31.05.2022 | Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics | HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integ... |
| 02.03.2022 | Alliance for Artificial Intelligence in Healthcare Elects New Board Leadership for 2022 | “AI will continue to have a demonstrable impact on human health. Having spent the last three years ideating with my fellow charter members to establish AAIH, I’m honored to take the reins and thrilled I get to engage with an incredible team... |
| 10.02.2022 | NUROSENE & CYCLICA PARTNER TO DEVELOP NOVEL DRUGS FOR NEURODEGENERATIVE DISEASES | Nurosene's NetraAI Engine at the forefront to accelerate Drug Discovery with Leading Pharma Research Company TORONTO, Feb. 10, 2022 /PRNewswire/ - Nurosene Health Inc. ("Nurosene" or the "Company") (CSE: MEND) (Frankfurt... |
| 17.11.2021 | From Cancer To COVID, Can AI Help Find The Next Blockbuster Drug? | Deep-learning technology allows Toronto-based biotech firm Cyclica to help researchers, companies and governments do drug discovery in record time—including in the COVID-19 crisis. |
| 07.10.2021 | Luciole Pharmaceuticals and Cyclica Announce Research Collaboration to Accelerate Discovery of Novel Medicines | NATICK, Mass. and TORONTO, Oct. 7, 2021 /PRNewswire/ -- Luciole Pharmaceuticals, a startup company focused on the discovery and development of small molecules that enhance the repair of oxidative damage to mitochondrial DNA (mtDNA), and Cyc... |
| 24.06.2020 | Cyclica banks $17M to decentralize drug discovery, speed drug development W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Cyclica started out licensing its drug-design software to biopharma companies, but it quickly realized that route was “simply not inspiring.” Rather than zeroing in on a particular disease area like a traditional biotech or teaming up with ... |
Show more